Latest Regulatory Progress News

Elsight Limited has reported a staggering 12-fold revenue increase in Q1 2026 to US$11.6 million, driven by strong U.S. defence contracts and early commercial traction. The company also soft-launched a GNSS-denied positioning product, marking a strategic shift toward a broader uncrewed systems platform.

Jindalee Lithium is set to list its McDermitt lithium project on NASDAQ through a US SPAC deal valuing the assets at US$571 million, while securing key US federal approvals and advancing magnesium by-product potential.

Firebrick Pharma secured regulatory approval for Nasodine Nasal Spray in Indonesia and launched Nasodine Throat Spray in Singapore and Fiji, while raising $1.5 million to fuel growth. The company aims to quadruple its product and market footprint within three years.

Recce Pharmaceuticals has cleared a critical regulatory hurdle in Indonesia with a successful inspection of its Phase 3 clinical trial site for diabetic foot infections, paving the way for potential approval in 2026 amid a large and growing market.

Vintage Energy and Vault Energy have agreed to negotiate a gas sales deal for Cullen-1 gas, aiming to fuel modular data centres onsite if flow tests confirm commercial viability. Vintage plans to fund testing via farm-out once permit tenure is secured.

Buru Energy has enhanced the Rafael Gas Project’s mid-case value by over 45% through new engineering insights, while securing A$5.3 million to advance development. The company delayed appraisal drilling to 2027 to optimise funding and project design, and navigates a leadership change with CEO Thomas Nador stepping down.

Invictus Energy has raised $10 million in a placement to fund the drilling of the Musuma-1 exploration well, targeting a substantial gas and condensate resource in Zimbabwe’s Cabora Bassa Basin. The well, planned for H2 2026, aims to build on the Mukuyu discovery and accelerate commercial development.

Anson Resources has lodged an updated Small Mining Operations notice for its 10,000tpa Green River lithium carbonate plant in Utah, marking the last significant regulatory hurdle before construction. The revised plant layout, backed by a near-complete Pre-feasibility Study, leverages existing infrastructure and private land ownership to enhance project bankability.

Lumos Diagnostics has secured a key FDA 510(k) clearance with CLIA waiver for its FebriDx rapid test, unlocking a US$1 billion-plus market opportunity and triggering milestone payments exceeding US$6 million. The company reported a 37% revenue jump in Q3 FY26, supported by a A$20 million placement and ongoing clinical and development projects.

Patrys has raised A$3.2 million through a share placement to fund its injectable quetiapine program’s Phase 1A clinical trial and FDA pre-IND preparations.

BMC Minerals has kicked off its 2026 drilling campaign at the Kudz Ze Kayah Project with a standout massive sulphide intercept at the Krakatoa Zone, pointing to potential extensions beyond current reserves and a longer mine life.

29Metals Limited (ASX:29M) swung to a $24 million net profit in 2025, powered by steady copper output at Golden Grove despite seismic disruptions, cost efficiencies, and key progress on growth projects including Gossan Valley and Capricorn Copper restart.